The "Ultimate Triple PET": 68Ga-DOTATATE, 18F-FDG, and 18F-Fluciclovine PET/CT Findings in a Single Patient With Metastatic Abdominal Carcinoid and Prostate Cancer

Matthew Mcclenathan, Justin G. Peacock*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

A 71-year-old man with a history of carcinoid and prostate adenocarcinoma underwent 68Ga-DOTATATE PET/CT to evaluate new mediastinal lymphadenopathy. The scan revealed new carcinoid metastases, but the mediastinal nodes were not avid. 18F-FDG PET/CT was performed to evaluate for cardiac and mediastinal sarcoidosis, revealing a lack of cardiac sarcoidosis, but probable mediastinal sarcoidosis. 18F-Fluciclovine PET/CT was then performed for possible prostate metastases, revealing the patient's known prostate cancer. Three different PET radiopharmaceuticals revealed 3 different processes in a single patient within a 195-day period, demonstrating the power of nuclear medicine diagnostics.

Original languageEnglish
Pages (from-to)E161-E164
JournalClinical Nuclear Medicine
Volume47
Issue number2
DOIs
StatePublished - 1 Feb 2022
Externally publishedYes

Keywords

  • DOTATATE
  • FDG
  • fluciclovine
  • PET

Cite this